BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of BMS-247550 when given
together with carboplatin in treating patients with recurrent or refractory solid tumors.
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Combining more than one drug may kill more tumor cells